Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pletal for Juvenile Raynaud's Phenomenon
NCT00048763Phase 4Completed
- Sponsor
- Otsuka America Pharmaceutical
- Start
- Oct 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cilostazol in Raynaud's phenomenon (RP), sponsored by Otsuka America Pharmaceutical. Primary endpoints: Number of Raynaud's Phenomenon episodes, Severity of Raynaud's Phenomenon symptoms and 1 more. Started Oct 2001; status: completed.
02
Drugs
cilostazol
03
Conditions
Raynaud's phenomenon (RP)
Beyond the preview
Go deeper on NCT00048763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048763.